1.
Walter RB, Medeiros BC, Gardner KM, Orlowski KF, Gallegos L, Scott BL, Hendrie PC, Estey EH. Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study. Haematologica [Internet]. 2014Jan.14 [cited 2026Nov.15];99(1):54-9. Available from: https://haematologica.org/article/view/6905